Atezolizumab vs best supportive care in resected NSCLC

Working to improve global cancer care access in low middle-income countries

ASCO Direct Highlights 2022: lung cancer highlights

Locally and advanced immunotherapy developments and new agents in lung cancer

Lung cancer immunotherapy adjuvant and neoadjuvant indications

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

ASCO and WHO to collaborate on quality indicators for cancer facilities

Spotlight on global cancer control at ASCO 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

ASCO 2022: Highlights and analysis

Updated data from the Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA x CD3 bispecific antibody